The Countermeasures Injury Compensation Program (CICP) was set up to address vaccine injuries associated with vaccines and other countermeasures during a pandemic or biothreat event. Due to specific federal legislation, a person cannot sue a manufacturer for an injury caused by a vaccine or other product listed as a countermeasure; they can only seek compensation from CICP by filing a claim. Shockingly, after 1.5 years after the rollout of gene therapy vaccines, the US government through CICP has only approved one claim and has yet to pay out a single
